Cell Signaling Pathways Flashcards
Toceranib phosphate blocks which receptors?
VEGF-R2
PDGF-R alpha/beta
KIT
FLT3
Masitinib blocks which receptors?
PDGF-R alpha/beta
KIT
Down regulation of what receptor is associated with worse prognosis for canine meningiomas?
Progesterone receptor
What kind of kinases are CDKs? (Phosphorylate what residues?)
Serine/threonine
In what phase of the cell cycle are levels of cyclin B highest?
Raise in anticipation and during M phase.
In what phase of the cell cycle are levels of cyclin D1 highest?
G1
In what phase of the cell cycle are levels of cyclin E highest?
Rise at end of G1, fall after R point and during S.
In what phase of the cell cycle are levels of cyclin A highest?
S phase
Does TGF-beta antagonize or facilitate cell proliferation and differentiation?
Antagonize
During what phase of the cell cycle is pRb hypophosphorylated?
G1 up till the restriction point
What are the initiator caspases in apoptosis (name 2)?
8 and 9
What are the effector caspases in apoptosis (name 3)?
3, 6, and 7
Pro-apoptotic or anti-apoptotic: Bcl-2?
anti
Pro-apoptotic or anti-apoptotic: Bax?
pro
Pro-apoptotic or anti-apoptotic: BAD?
pro
Pro-apoptotic or anti-apoptotic: BIM?
pro
Pro-apoptotic or anti-apoptotic: BCLXS?
pro
Pro-apoptotic or anti-apoptotic: BAK?
pro
Pro-apoptotic or anti-apoptotic: BOK?
pro
Pro-apoptotic or anti-apoptotic: BCLXL?
anti
Pro-apoptotic or anti-apoptotic: BCLW?
anti
Which of the following are involved in inhibition of cyclin B activity?
i. MYT1 kinase
ii. D3A kinase
iii. WEE1 kinase
iv. KIP1
a. i, iii, iv
b. ii, iv
c. i, ii
d. ii, iii, iv
a: MYT1, WEE1, KIP1
Explanation: p. 197 fig. 9-4, also text on p. 198 and 202. MYT1 and WEE1 phosphorylate CDKs that are cyclin-bound, which inactivates the CDKs. KIP1 can also inhibit CDKs by binding them. D3A is made up.
Choose the correct pairing of cyclin(s) and cyclin dependent kinase(s).
a. CDK1 – Cyclin E and Cyclin A
b. CDK2 – Cyclin C
c. CDK3 and CDK5 – Cyclin A and Cyclin B
d. CDK4 and CDK6 - Cyclin D
d - CDK4/6 and Cyclin D
Explanation: p. 198 and figure 9.5. CDK1 goes with A and B. CDK2 goes with E and A (cyclin C is made up). CDKs 3 and 5, are made up (actually, they probably exist but are not mentioned in text).
Which of the following could promote tumor development?
a. Increased activity of p16INK4A
b. A mis-sense mutation in the gene for Cyclin D1
c. Decreased activity of the E2F transcriptional program
d. An amino acid substitution that promotes binding of Cyclin B to CDK1
d - AA substitution promoting binding of CDK1-cyclin B
Explanation: (a) p16INK4A is an inhibitor of G1/S transition; increased activity would make it harder to proceed through the cell cycle. (b) Cyclin D1 is also required for G1/S transition, so an inactive gene product will make it harder to proceed through cell cycle. (c) The E2F transcriptional program codes for Cyclin E, Cyclin A2, and EMI1, which help reverse the inactivity of CDK1 and CKD2 in G1. (d) The Cyclin B/CDK1 complex facilitates transition from G2-> M; increased binding should make this more likely.